Medicine
Claforan 1 g powder for injection
Claforan 1 g powder for injection is a prescription medicine containing Cefotaxime for intramuscular, intravenous use, marketed by SteriMax, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store CLAFORAN dry powder at 20°C to 25°C (68°F to 77ºF), excursions permitted…
Key facts
- Active ingredient (INN)
- Cefotaxime
- Brand
- Claforan
- Strength
- 1 g
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials
- Marketing authorisation holder
- SteriMax
- Manufacturer
- SteriMax
- Origin register
- US FDA, United States
- Storage
- Store CLAFORAN dry powder at 20°C to 25°C (68°F to 77ºF), excursions permitted to 15ºC to 30ºC (59ºF to 86ºF) and should be protected from excessive light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD01 Cefotaxime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2026
- Identifiers
- RxCUI 1656313, 1656316DailyMed set ID 434fb630-c8d6-4583-b3ee-8e4ba6552c3dNDC 21586-031Application NDA050547
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 21586-031-02 | SteriMax | 1 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 March 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cefotaxime 1 g powder for injection.
Other strengths and forms of Cefotaxime
Clinical summary
Cefotaxime is a cephalosporin antibacterial indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. MedsAcross supplies Cefotaxime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefotaximeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CLAFORAN prescribing information (SteriMax) · U.S. National Library of Medicine, DailyMed
Need Claforan 1 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.